Surging Growth in Global Drug Infusion Systems Market: Foreseen to Reach $20.46 Billion by 2029 at a Compound Annual Growth Rate (CAGR) of 9.3%

"
Rapid advancements in healthcare technology and increasing prevalence of chronic diseases drive steady growth in the global drug infusion systems market.

What Is The Projected Market Size Of The Global Drug Infusion Systems Market And Its Growth Rate?
• The global drug infusion systems market is showing strong growth, moving from $13.42 billion in 2024 to $14.34 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.9%.
• This strong growth in the historic period is primarily due to shift to electronic infusion devices, increased prevalence of chronic diseases, advancements in patient care, home-based infusion therapy, and expansion of ambulatory care settings.
• The market size is projected to continue its robust growth, reaching an estimated $20.46 billion in 2029 at a CAGR of 9.3%.
• The key drivers of this forecasted growth include a shift towards disposable systems, rising prevalence of chronic diseases, expansion of ambulatory care facilities, personalized medicine and adaptive dosing, increasing demand for home-based care.

What Is Driving The Growth In The Drug Infusion Systems Market?
The growth of the drug infusion systems market is expected to be propelled by the increasing prevalence of chronic diseases like cancer, diabetes, cardiovascular disease, and autoimmune disorders. These illnesses often require long-term or continuous infusion therapy, which can be efficiently and effectively administered through drug infusion systems. The rapid increase in the prevalence of chronic diseases, particularly in low- and middle-income countries, bolsters market growth. For instance, according to the US-based Centers for Disease Control and Prevention (CDC), a growing number of people in America are dealing with multiple chronic conditions - 42% have two or more and 12% have five or more. Therefore, the rising prevalence of chronic diseases fuels the growth of the drug infusion systems market.

[Request a free sample copy](https://www.thebusinessresearchcompany.com/sample.aspx?id=10703&type=smp)

Who Are the Key Players Driving Drug Infusion Systems Market Growth?
• Medtronic plc
• Baxter International Inc.
• ICU Medical Inc.
• Becton Dickinson and Company
• Smiths Group plc
• Tandem Diabetes Care Inc.
• Terumo Corporation
• Halyard Health Inc.
• Insulet Corporation
• Zyno Medical Inc.
• B. Braun Melsungen AG
• Flowonix Medical Inc.
• IRadimed Corporation
• Moog Inc.
• Debiotech S.A.

What Are The Key Trends In The Drug Infusion Systems Market?
• Shift towards disposable systems
• Rising prevalence of chronic diseases
• Expansion of ambulatory care facilities
• Emergence of personalized medicine and adaptive dosing
• Increasing demand for home-based care
• Wireless connectivity and remote monitoring
• Integration with electronic health records (ehr)
• Introduction of smart pump technology
• Personalized and adaptive dosing
• Development of minimally invasive infusion techniques

What Are The Segments Of The Global Drug Infusion Systems Market?
• By Product Type: Elastomeric Infusion System, Disposable Infusion System, Syringe Infusion System, Peristaltic Pump, Multi-Channel Pump, Patient-Controlled Analgesia (PCA) Pump, Insulin Pump, Implantable Infusion System
• By Route Of Administration: Intravenous, Subcutaneous, Arterial, Epidural, Other Routes Of Administration
• By Application: Oncology And Chemotherapy, Diabetes, Analgesia, Nutrition, Hematology, Pediatrics, Other Applications
• By End User: Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Other End Users

Which Region Leads The Drug Infusion Systems Market?
North America was the largest region in the drug infusion systems market in 2024. However, the Asia-Pacific region is expected to witness the fastest growth during the forecast period, mainly due to rapidly developing healthcare infrastructure, increasing prevalence of chronic diseases, and growing acceptance of advanced healthcare technologies.

[Pre-book the report for swift delivery](https://www.thebusinessresearchcompany.com/report/drug-infusion-systems-global-market-report)

What Is Covered In The Drug Infusion Systems Market Global Market Report?
- Market Size Analysis: Analyze the Drug Infusion Systems Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Drug Infusion Systems Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Drug Infusion Systems Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Drug Infusion Systems Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

[Request customization for this report](https://www.thebusinessresearchcompany.com/Customise?id=10703&type=smp)

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company is a leading provider of business intelligence and consulting services, with over 15,000 reports covering 27 industries across 60 geographies. We offer well-researched, reliable, and data-rich research solutions to help our clients stay ahead in a competitive business environment. Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to aid in informed decision-making.

This release was published on openPR.